The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma

Acta Histochemica

Volumn 114, Issue 6, 2012, Pages 582-588

  Jiang, Li ^a   Lv, Xiaoxing ^a   Li, Jing ^a   Li, Jinqing ^a   Li, Xueyong ^a   Li, Wangzhou ^a   Li, Yuejun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antisense; Chemosensitivity; Cutaneous melanoma; MicroRNA 21; Prognosis; Radiosensitivity

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; CISPLATIN; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ADULT; ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; APOPTOSIS; ARTICLE; BRESLOW THICKNESS; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DYSPLASTIC NEVUS; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA CELL; MELANOMA METASTASIS; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PROTEIN TARGETING; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; MELANOMA; MICRORNAS; MULTIVARIATE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84861652578     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.11.001     Document Type: Article

References (36)

1. Ali S., Ahmad A., Banerjee S., Padhye S., Dominiak K., Schaffert J.M., et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 2010, 70:3606-3617.
2. Belver L., Papavasiliou F.N., Ramiro A.R. MicroRNA control of lymphocyte differentiation and function. Curr Opin Immunol 2011, 23:368-373.
3. Bhatti I., Lee A., James V., Hall R.I., Lund J.N., Tufarelli C., et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. Gastrointest Surg 2011, 15:199-208.
4. Bourguignon L.Y., Spevak C.C., Wong G., Xia W., Gilad E. Hyaluronan-CD44 interaction with protein kinase (Cepsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 2009, 284:26533-26546.
5. Braun T., Gautel M. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 2011, 12:349-361.
6. Carnero A., Blanco-Aparicio C., Renner O., Link W., Leal J.F. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 2008, 8:187-198.
7. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67:8433-8438.
8. Dillhoff M., Liu J., Frankel W., Croce C., Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 2008, 12:2171-2176.
9. Hiyoshi Y., Kamohara H., Karashima R., Sato N., Imamura Y., Nagai Y., et al. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009, 15:1915-1922.
10. Huang G.L., Zhang X.H., Guo G.L., Huang K.T., Yang K.Y., Shen X., et al. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep 2009, 21:673-679.
11. Jazbutyte V., Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010, 11:926-935.
12. Jovanovic M., Hengartner M.O. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25:6176-6187.
13. Koturbash I., Zemp F.J., Pogribny I., Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutat Res 2011, 722:94-105.
14. Lai E.C. Micro RNAs are complementary to 3'UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002, 30:363-364.
15. Li T., Li D., Sha J., Sun P., Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 2009, 383:280-285.
16. Liu C., Yu J., Yu S., Lavker R.M., Cai L., Liu W., et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 2010, 53:98-107.
17. Ma W.J., Lv G.D., Tuersun A., Liu Q., Liu H., Zheng S.T., et al. Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol Biol Rep 2011, 38:3253-3260.
18. Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008, 54:1696-1704.
19. McManus M.T. MicroRNAs and cancer. Semin Cancer Biol 2003, 13:253-258.
20. Miller A.J., Mihm M.C., Melanoma N. Engl J Med 2006, 355:51-65.
21. Muntoni F., Wood M.J. Targeting RNA to treat neuromuscular disease. Nat Rev Drug Discov 2011, 10:621-637.
22. Motoyama K., Inoue H., Mimori K., Tanaka F., Kojima K., Uetake H., et al. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 2010, 36:1089-1095.
23. Nana-Sinkam S.P., Croce C.M. MicroRNAs as therapeutic targets in cancer. Transl Res 2011, 157:216-225.
24. Pan X., Wang Z.X., Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther 2011, 10:1224-1232.
25. Park J.K., Lee E.J., Esau C., Schmittgen T.D. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 2009, 38:e190-e199.
26. Ren Y., Zhou X., Mei M., Yuan X.B., Han L., Wang G.X., et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 2010, 10:27.
27. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011, 91:827-887.
28. Shah A.A., Leidinger P., Blin N., Meese E. miRNA: small molecules as potential novel biomarkers in cancer. Curr Med Chem 2010, 17:4427-4432.
29. Shenouda S.K., Alahari S.K. MicroRNA function in cancer: oncogene or a tumor suppressor?. Cancer Metastasis Rev 2009, 28:369-378.
30. Shibuya H., Iinuma H., Shimada R., Horiuchi A., Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010, 79:313-320.
31. Song B., Wang C., Liu J., Wang X., Lv L., Wei L., et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 2010, 29:29.
32. Terando A., Sabel M.S., Sondak V.K. Melanoma: adjuvant therapy and other treatment options. Curr Treat Options Oncol 2003, 4:187-199.
33. Tsuchiya S., Okuno Y., Tsujimoto G. MicroRN.A: biogenetic and functional mechanisms and involvements in cell differentiation and cancer. J Pharmacol Sci 2006, 101:267-270.
34. Wang Z.X., Lu B.B., Wang H., Cheng Z.X., Yin Y.M. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res 2011, 42:281-290.
35. Yang C.H., Yue J., Pfeffer S.R., Handorf C.R., Pfeffer L.M. MicroRNA-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 2011 Sep 22.
36. Zhang J.G., Wang J.J., Zhao F., Liu Q., Jiang K., Yang G.H. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010, 411:846-852.